The Melbourne Centre for Nanofabrication (MCN) is a world class infrastructure that drives Australian innovation of micro and nanotechnologies. MCN is directed by Professor Nicolas Voelcker (also deputy director of the ARC CPTT) and linked to the National Collaborative Research Infrastructure Strategy (NCRIS) funding. MCN has been instrumental in progressing several of the ARC CPTT … Continue reading MCN: an essential infrastructure and services to drive ARC CPTT innovation
Our editorial “The FDA modernisation act 2.0: bringing non-animal technologies to the regulatory table” is now available online
The FDA modernisation act 2.0 was passed in late 2022 enabling drug registration without animal studies and bringing microphysiological systems (MPS) to the regulatory table.To learn more about the act and the future regulatory role of MPS, read our editorial published in Drug Discovery Today: https://www.sciencedirect.com/science/article/pii/S1359644623000120